BAICX | DIFEX | BAICX / DIFEX | |
Total Expense Ratio | 0.82 | 1.14 | 72% |
Annual Report Gross Expense Ratio | 0.92 | 1.20 | 77% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 5.480 | 3.542 | 155% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | 100 | N/A | - |
Net Assets | 10.4B | 1.91B | 544% |
Annual Yield % from dividends | 5.74 | 4.52 | 127% |
Returns for 1 year | 9.98 | 6.95 | 144% |
Returns for 3 years | 25.78 | 17.03 | 151% |
Returns for 5 years | 29.29 | 18.07 | 162% |
Returns for 10 years | 52.60 | 35.70 | 147% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 65.85 | 0.14 | +0.21% |
Janus Henderson Global Life Sciences N | |||
FDIGX | 84.71 | N/A | N/A |
Fidelity Advisor Consumer Staples I | |||
PQUAX | 12.03 | N/A | N/A |
PACE Small/Medium Co Growth Equity A | |||
GDSRX | 24.14 | N/A | N/A |
Goldman Sachs Small Cap Eq Insghts R | |||
TCMIX | 17.56 | N/A | N/A |
AMG TimesSquare International SmallCap Z |